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biomarkers of disease or disease therapy outcome is widely used and the present work shows some, despite very limited, degree of novelty. Very limited or absent attention is given to the description of the conditions of the experimental procedures originally used to obtain the biological samples and the data actually reanalyzed. This is clearly reflected also in the mistake made by the authors in reporting the number of the animals that underwent MCAO; the latter is 3 and should be corrected in 6. Finally, despite the number of genes, PPI and miRNAs reanalyzed the discussioni is very scanty and the Authors should be encouraged to describe better the value of their work.
